Biomin is the first company in the world to receive a positive European Food Safety Authority (EFSA) – opinion on mycotoxin biotransformation.
In their scientific opinion, EFSA concluded that Biomin BBSH 797 (part of the well-established Mycofix product line) is not only safe for animals, humans and the environment, but also demonstrably efficacious in target species.
Following a request from the European Commission, the FEEDAP Panel acknowledged the product’s efficacy to reduce the epoxide group of trichothecenes to produce less toxic and thus, harmless metabolites. The Panel concluded that the evidence presented in ex vivo and in vivo studies confirms that this efficacy can be realised in animals when the additive is incorporated into trichothecene-contaminated diets.
Trichothecenes comprise the largest group of mycotoxins, the agriculturally most important thereof belonging to type A- (e.g.: T-2 toxin, diacetoxyscirpenol) or type B- trichothecenes (e.g.: deoxynivalenol, nivalenol). They are one of the major mycotoxins groups affecting not just Europe but worldwide. According to the latest Biomin mycotoxin survey report 2012 which analysed 4,023 samples worldwide, DON was found in 64 % of all samples with an average contamination of over 1000 pbb in all tested samples.
"*" indicates required fields
Notifications
Your Privacy Matters
It's your legal right to choose which information a website may store and have access to. With your permission, we and our third-party partners (18) store and/or access information on a device, such as unique identifiers in cookies and browsing data to collect and process personal data.
We and our partners do the following data processing:
Store and/or access information on a device, Advertising based on limited data and advertising measurement, Personalised content, content measurement, audience research, and services development
If you accept any or all of these, you will have agreed to this website's use of cookies for these purposes. You may also choose to refuse consent, but certain personalized features of the site won't be available to you.